Supplementary
Classifier 2 miR-101-3p + miR-106b-3p -51.75 + 9.83 x miR-101-3p + 20.34 x miR-106b-3p
Classifier 3 miR-101-3p + miR-1246 -2.43 + 0.48 x miR-101-3p + 1.27 x miR-1246
Classifier 4 miR-106b-3p + miR-1246 -7.91 + 2.45 x miR-106b-3p + 1.79 x miR-1246 Serum HCC vsCirrhosis Classifier miR-101-3p + miR-106b-3p -2.49 -0.26 x miR-101-3p + 2.09 x miR-106b-3p
Supplementary 
Sex
Male n = 11 n = 5 1.00E + 00 n = 13 n = 3 2.00E-01 n = 8 n = 8 1.00E + 00
Female n = 4 n = 2 n = 3 n = 3 n = 4 n = 2
Age(years)
˂ 60 n = 1 n = 1 1.00E + 00 n = 0 n = 2 6.00E-02 n = 1 n = 1 1.00E + 00 ≥ 60 n = 14 n = 6 n = 16 n = 4 n = 11 n = 9 Etiology HBV n = 6 n = 1 1.00E-01 n = 6 n = 1 3.00E-01 n = 6 n = 1 3.00E-01
G2-G4 n = 11 n = 6 n = 13 n = 4 n = 10 n = 7
AFP (ng/µl)
˂ 20 n = 3 n = 3 3.00E-01 n = 4 n = 2 1.00E + 00 n = 4 n = 4 1.00E-01 ≥ 20 n = 12 n = 4 n = 12 n = 4 n = 8 n = 6
Nodule size(cm) ˂ 3 n = 4 n = 3 6.00E-01 n = 5 n = 2 1.00E + 00 n = 4 n = 3 1.00E + 00 ≥ 3 n = 11 n = 4 n = 11 n = 4 n = 8 n = 7 a The mean value of plasma copies / ul was chosen as cutoff value.
